Charles Brink

2.3k total citations
53 papers, 1.9k citations indexed

About

Charles Brink is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Charles Brink has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Physiology, 18 papers in Pulmonary and Respiratory Medicine and 16 papers in Pharmacology. Recurrent topics in Charles Brink's work include Asthma and respiratory diseases (30 papers), Inflammatory mediators and NSAID effects (12 papers) and Nitric Oxide and Endothelin Effects (10 papers). Charles Brink is often cited by papers focused on Asthma and respiratory diseases (30 papers), Inflammatory mediators and NSAID effects (12 papers) and Nitric Oxide and Endothelin Effects (10 papers). Charles Brink collaborates with scholars based in France, United States and Sweden. Charles Brink's co-authors include Xavier Norel, Carlos Labat, Sven‐Erik Dahlén, Laurence Walch, Jean‐Pierre Gascard, Charles N. Serhan, Takehiko Yokomizo, Jeffrey M. Drazen, Douglas W.P. Hay and Takao Shimizu and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Pharmacological Reviews.

In The Last Decade

Charles Brink

52 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Brink France 25 827 631 441 383 356 53 1.9k
Xavier Norel France 33 1.1k 1.3× 638 1.0× 645 1.5× 321 0.8× 634 1.8× 105 2.7k
Xiang Fang United States 27 333 0.4× 920 1.5× 317 0.7× 288 0.8× 119 0.3× 87 2.2k
Aksam Merched France 19 441 0.5× 831 1.3× 94 0.2× 441 1.2× 180 0.5× 30 2.1k
Jwu‐Lai Yeh Taiwan 27 401 0.5× 807 1.3× 286 0.6× 161 0.4× 161 0.5× 121 2.0k
Kyungho Chang Japan 12 568 0.7× 704 1.1× 124 0.3× 377 1.0× 116 0.3× 33 1.9k
Chandrashekhar R. Gandhi United States 35 538 0.7× 945 1.5× 143 0.3× 452 1.2× 107 0.3× 93 3.5k
Barry L. Tepperman Canada 24 649 0.8× 472 0.7× 102 0.2× 196 0.5× 206 0.6× 70 1.6k
Hozuka Akita Japan 27 754 0.9× 658 1.0× 153 0.3× 301 0.8× 94 0.3× 79 2.4k
Leonard M. Hillegass United States 20 279 0.3× 681 1.1× 170 0.4× 497 1.3× 134 0.4× 42 2.1k
Armin Hatzelmann Germany 36 1.3k 1.6× 2.1k 3.4× 785 1.8× 809 2.1× 575 1.6× 58 3.6k

Countries citing papers authored by Charles Brink

Since Specialization
Citations

This map shows the geographic impact of Charles Brink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Brink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Brink more than expected).

Fields of papers citing papers by Charles Brink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Brink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Brink. The network helps show where Charles Brink may publish in the future.

Co-authorship network of co-authors of Charles Brink

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Brink. A scholar is included among the top collaborators of Charles Brink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Brink. Charles Brink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bäck, Magnus, Charles Brink, Nan Chiang, et al.. (2019). Leukotriene receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database. IUPHAR/BPS Guide to Pharmacology CITE. 2019(4). 1 indexed citations
2.
Labat, Carlos, M. Temmar, Edit Nagy, et al.. (2013). Inflammatory mediators in saliva associated with arterial stiffness and subclinical atherosclerosis. Journal of Hypertension. 31(11). 2251–2258. 49 indexed citations
3.
Chiang, Nan, Charles N. Serhan, Sven‐Erik Dahlén, et al.. (2006). The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo. Pharmacological Reviews. 58(3). 463–487. 378 indexed citations
4.
Bäck, Magnus, Maria Costantino, Charles Brink, & Xavier Norel. (2005). Effect of cold storage on cholinergic responses induced by electrical field stimulation in human bronchi. Pulmonary Pharmacology & Therapeutics. 19(4). 297–302. 3 indexed citations
5.
Chastre, Eric, et al.. (2005). Cholinesterase activity in human pulmonary arteries and veins: correlation with mRNA levels. Life Sciences. 76(19). 2211–2220. 2 indexed citations
6.
Norel, Xavier, Vincent de Montpréville, & Charles Brink. (2004). Vasoconstriction induced by activation of EP1 and EP3 receptors in human lung: effects of ONO-AE-248, ONO-DI-004, ONO-8711 or ONO-8713. Prostaglandins & Other Lipid Mediators. 74(1-4). 101–112. 51 indexed citations
7.
Brink, Charles, Sven‐Erik Dahlén, Jeffrey M. Drazen, et al.. (2003). International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors. Pharmacological Reviews. 55(1). 195–227. 228 indexed citations
8.
Brink, Charles. (2003). Leukotriene Receptors: State of the Art. Advances in experimental medicine and biology. 525. 7–10. 6 indexed citations
9.
Bäck, Magnus, Xavier Norel, Laurence Walch, et al.. (2002). The Contraction of the Human Pulmonary Artery by LTC4 is Resistant to CYSLT1 Antagonists and Counteracted by Prostacyclin Release. Advances in experimental medicine and biology. 507. 315–319. 2 indexed citations
10.
Roger, Patricia, Jean‐Pierre Gascard, Jacques Bara, Vincent de Montpréville, & Charles Brink. (2001). MUC5AC mucin release from human airways in vitro: Effects of indomethacin and Bay X1005. Mediators of Inflammation. 10(1). 33–36. 1 indexed citations
11.
Walch, Laurence, Xavier Norel, Jean‐Pierre Gascard, & Charles Brink. (2000). Functional Studies of Leukotriene Receptors in Vascular Tissues. American Journal of Respiratory and Critical Care Medicine. 161(Supplement_1). S107–S111. 42 indexed citations
12.
Gascard, Jean‐Pierre, et al.. (2000). Evidence for a M1 muscarinic receptor on the endothelium of human pulmonary veins. British Journal of Pharmacology. 130(1). 73–78. 38 indexed citations
13.
Roger, Patricia, Jean‐Pierre Gascard, Vincent de Montpréville, & Charles Brink. (1999). Basal Secretion of Lysozyme from Human Airways in Vitro. Mediators of Inflammation. 8(6). 319–323. 3 indexed citations
14.
Brink, Charles, et al.. (1999). LTE4 Blood Levels in Infants with Congenital Heart Lesions. Advances in experimental medicine and biology. 469. 307–311.
15.
Norel, Xavier, Laurence Walch, Carlos Labat, et al.. (1999). Prostanoid receptors involved in the relaxation of human bronchial preparations. British Journal of Pharmacology. 126(4). 867–872. 76 indexed citations
16.
Hervé, Philippe, et al.. (1995). l-arginine and pentoxifylline attenuate endothelial dysfunction after lung reperfusion injury in the rabbit. The Annals of Thoracic Surgery. 60(3). 646–650. 26 indexed citations
17.
Serraf, Alain, Philippe Hervé, Carlos Labat, et al.. (1995). Endothelial dysfunction in venous pulmonary hypertension in the neonatal piglet. The Annals of Thoracic Surgery. 59(5). 1155–1161. 4 indexed citations
18.
Labat, Carlos, Jacques Cerrina, Bernadette Raffestin, & Charles Brink. (1989). Effects of Thiazinamium Chloride on Human Isolated Bronchial Muscle Preparations. Respiration. 55(4). 220–226. 1 indexed citations
19.
Delautier, Danièle, et al.. (1988). Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels. European Journal of Pharmacology. 147(1). 1–6. 20 indexed citations
20.
Labat, Carlos, et al.. (1988). Evidence that the histamine sensitivity and responsiveness of guinea‐pig isolated trachea are modulated by epithelial prostaglandin E2production. British Journal of Pharmacology. 95(1). 300–308. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier Norel Breakdown of academic impact, for papers by Xiang Fang Breakdown of academic impact, for papers by Aksam Merched Breakdown of academic impact, for papers by Jwu‐Lai Yeh Breakdown of academic impact, for papers by Kyungho Chang Breakdown of academic impact, for papers by Chandrashekhar R. Gandhi Breakdown of academic impact, for papers by Barry L. Tepperman Breakdown of academic impact, for papers by Hozuka Akita Breakdown of academic impact, for papers by Leonard M. Hillegass Breakdown of academic impact, for papers by Armin Hatzelmann
Rankless by CCL
2026